ADVAIR HFA 115 ug/1
fluticasone propionate and salmeterol xinafoate · AEROSOL, METERED · GlaxoSmithKline LLC
ADVAIR HFA is a aerosol, metered containing fluticasone propionate and salmeterol xinafoate at 115 ug/1, taken respiratory (inhalation). Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- ADVAIR HFA
- Generic Name
- fluticasone propionate and salmeterol xinafoate
- NDC Code (Product)
0173-0716- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 115 ug/1
- Dosage Form
- AEROSOL, METERED
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA021254
- Marketing Start
- 09/29/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is ADVAIR HFA used for?
ADVAIR HFA contains fluticasone propionate and salmeterol xinafoate. It is a aerosol, metered taken respiratory (inhalation). Consult your doctor for specific uses.
Is ADVAIR HFA a controlled substance?
ADVAIR HFA is not classified as a controlled substance by the DEA.
What is the generic name for ADVAIR HFA?
The generic name for ADVAIR HFA is fluticasone propionate and salmeterol xinafoate. There are 3 other brand versions of fluticasone propionate and salmeterol xinafoate.
What is the NDC code for ADVAIR HFA 115 ug/1?
The NDC (National Drug Code) for ADVAIR HFA 115 ug/1 is 0173-0716, listed by GlaxoSmithKline LLC.